Reports of recent insider buying at these two model portfolio names are lifting their shares today. Here are the details.
Shares of this medical instruments supplier keep pushing higher so we booking some gains and changing our rating to a Two.
As earnings season wrapped up this week, we added shares to one model portfolio position and trimmed one other.
But with global demand growing for its services increasing, this name's shares are attractive to purchase on pullbacks.
Despite the earnings miss, we believe the stock remains undervalued, given the company's pristine balance sheet.
This pharmaceutical name is trading higher this morning on news of its better-than-expected quarterly results.
News that the company is poised to sign a big deal with a large pharmaceutical partner is driving the upside.
Here is what we'll be focusing on when this theatrical equipment supplier and drilling name report on Friday.
Here are the updates that we'll be listening for when these two companies report later today and tomorrow morning.
We are also lowering our rating on the name.